Course curriculum

    1. ABP-7

    2. AOD-9604 (Advanced Obesity Drug)

    3. ARA-290

    4. Researched Benefits of ARA-290

    5. Bremelanotide (PT-141)

    6. Bremelanotide PT-141

    7. PT-141

    8. BPC-157

    9. Cerebrolysin

    10. CJC-1295 / IPAMORELIN Injectable

    11. Delta Sleep-Inducing Peptide (DSIP)

    12. DSIP (Delta Sleep Inducing Peptide)

    13. Dihexa

    14. Epithalon: Quick Review

    15. Epithalon

    16. Elampretide (SS-31)

    17. FG Loop (FGL)

    18. GHK-Cu

    19. GLP-1 Injectable / Capsules

    20. Ibutamoren Mesylate (MK-677)

    21. IGF-1

    22. IGF--1 (LR3)

    23. IGF-1 (LR3)

    24. Ipamorelin

    25. Kisspeptin-10

    26. Kisspeptin

    27. KPV

    28. Liraglutide

    29. LL-37

    30. Melanotan I

    31. MOTS-c

    32. Mitochondrial Peptides MOTS-c

    33. Melanotan II

    34. NAD+

    35. Nicotinamide Riboside

    36. NMN (Nicotinamide Mononucleotide)

    37. Oxytocin

    38. Pegylated Mechano Growth Factor (PEG-MGF)

    39. Selank

    40. PTD-DBM

    41. Retatrutide

    42. Semax

    43. Sermorelin Acetate

    44. Semaglutide

    45. Sermorelin/Ipamorelin

    46. Thymulin

    47. Tesamorelin

    48. Tesofensine

    49. Thymosin-Alpha 1 (Ta-1)

    50. Thymosin Beta-4 (TB-4)

    51. Tirzepatide

    52. Valproic Acid + PTD-DBM

    53. Vasoactive Intestinal Peptide (VIP)

    54. Zinc Thymulin: The Powerful Peptide for Boosting Hair Growth

    1. Quick Peptide Reference Charts

    2. Downloadable Quick Peptide Reference Charts

About this course

  • $499.00
  • 56 lessons

Meet Our Expert

Justin Kirkland, Chemist

Peptide Therapy

Justin Kirkland is a longevity medicine expert who caters his educational expertise to healthcare providers. He holds a BS in Agronomy and an MS in Biology, and attended medical school in Belize at the Central American Health Sciences University. He was awarded a U.S. patent for the improved synthesis of the ergoline BOL-148: useful in treating cluster headaches and has many other filed patents. He has years of experience in pharmaceutical drug development, patent filing, and pharmacology, and has worked as one of the industry’s leading peptide chemists. Justin is known globally for producing clinical trial materials in Canada for both the medical use of psilocybin mushroom micro-dosing for the treatment of depression and MDMA for PTSD studies. As the founding scientist and CEO of Nutraneeds, a nutraceutical company that provides key products for medical practitioners, he has developed products, manufactured unique formulations, and developed safe and effective supplements endorsed by the medical community as invaluable for their patients. Justin is currently pursuing future drug development research in conjunction with The University of Miami Miller School of Medicine, Molecular Biology, and Biochemistry Ph.D. program.